Clinical Trial Update: Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). [Phase 3]

View source ↗

Summary

A phase 3 trial (POSEIDON) comparing durvalumab + tremelimumab with chemotherapy versus durvalumab with chemotherapy and chemotherapy alone in non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer NSCLC | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-04-07